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and	 sporadic	 forms	 of	 nephrotic	 syndrome	 (NS).	 Patients	 with	 NS	 often	 present	
symptoms	of	volume	retention,	such	as	oedema	formation	or	hypertension.	The	pri‐
mary	dysregulation	 in	 sodium	handling	 involves	an	 inappropriate	activation	of	 the	
epithelial	sodium	channel,	ENaC.	Plasma	proteases	in	a	proteinuria‐dependent	fash‐
ion	 have	 been	made	 responsible;	 however,	 referring	 to	 the	 timeline	 of	 symptoms	












plasmin	 occurs	 in	 the	 urine	 and	 additional	 cleavage	 of	 γENaC	 is	 encountered.	 In	
conclusion,	characterizing	the	volume	handling	of	Nphs2∆pod	revealed	early	sodium	
retention	occurring	independent	to	aberrantly	filtered	plasma	proteases.	As	an	un‐
derlying	mechanism	cathepsin	B	 induced	αENaC	processing	 leading	 to	augmented	
channel	activity	and	hypertension	was	identified.
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was	 shown	 to	 be	 an	 intrarenal	 defect4	 located	 beyond	 the	 distal	
convolutions	 in	 the	 renal	 connecting	 tubule	 and	 collecting	 ducts.	
Abnormal	high	activity	of	the	epithelial	sodium	channel	(ENaC)	was	
proven	to	be	the	reason	for	the	increased	transepithelial	sodium	re‐




of	 the	 ENaC	 subunits	 alpha	 and	 gamma.6‐9	 In	 animal	models	with	
NS,	 the	 increased	 expression	 level	 of	 ENaC	was	 demonstrated	 to	








proteases,	are	needed	for	 the	second	 incision	 in	γENaC	to	release	
the	inhibitory	tract.	Several	proteases	processing	γENaC	were	iden‐
tified12,13	including	plasmin	in	the	development	of	NS.14,15
Regarding	 the	 timeline	 of	 the	 appearance	 of	 sodium	 retention	
and	proteinuria,	 contradictory	 results	 have	been	published.	 In	 the	
rat	model	of	PAN‐induced	nephrosis,	sodium	retention	was	shown	
to	start	before	or	at	 the	same	time	as	 the	onset	of	proteinuria.7,16 
Consequently,	the	question	arises	whether	glomerular	plasmin	leak‐
age	is	the	only	mechanism	for	ENaC‐induced	sodium	retention.	Both,	
the	 rat	model	of	PAN‐induced	nephrosis	 and	 the	mouse	model	of	











and	 to	 identify	 new	mechanism	 for	 the	dysregulated	 sodium	han‐
dling	during	the	development	of	NS.
We	 used	 Nphs2fl/fl(control)	 and	 Nphs2fl/flcrossbred with induc‐
ible	 podocyte‐specific	 Cre recombinase	 transgenic	 mice,	 termed	
Nphs2∆pod	 hereafter	 and	 found	 that	 sodium	 retention	 and	 hy‐
pertension	 established	 before	 the	 onset	 of	 an	 unselective	 gross	
proteinuria.	Increased	ENaC	channel	activity,	proteolytic	processing	
of	αENaC	 together	with	 the	 appearance	of	 proteases	 in	 the	urine	
were	encountered.	Among	several	lysosomal	enzymes	identified	by	
proteomic	analysis,	only	cathepsin	B	was	able	to	cleave	αENaC	and	
augment	channel	 activity.	 Inhibition	of	 cathepsin	B	 influenced	 the	






for	 the	 care	 and	 use	 of	 Laboratory	 animals,	 as	well	 as	 the	 Swiss	
and	 German	 law	 for	 the	 welfare	 of	 animals	 and	 were	 approved	
by	 local	 authorities	 (2013_06E_FR,	 23614;	 2016_28_FR,	 28328;	
V242‐20597/2018).	Mice	were	housed	in	a	SPF	facility	with	free	ac‐
cess	to	chow	and	tap	water	and	a	12‐hour	day/night	cycle.	Breeding	
and	 genotyping	 was	 performed	 as	 described.3 Nphs2fl/fl(control)	
and	 Nphs2fl/flcrossbred with	 inducible	 podocyte‐specific	 Cre re‐
combinase	transgenic	mice,	termed	Nphs2∆pod,3	were	used.	For	the	










tor	 CA‐074Me	 (MerckMillipore,	 Darmstadt,	 Germany).	 Six	 weeks	
old	Nphs2∆pod	and	control	received	Me‐074	or	vehicle	by	osmotic	






2.2 | Presentation of data and statistical analysis
Quantitative	data	are	presented	as	means	±	SEM.	Statistical	compar‐
isons	were	performed	with	the	GraphPad	Prism	Software	Package	
6	 (GraphPad	Software	 Inc,	La	 Jolla,	CA,	USA).	For	 statistical	 com‐
parison,	the	non‐parametric	Mann–Whitney	U	test,	the	parametric	
two‐tailed	Student’s	t	test	and,	where	appropriate	one‐way	ANOVA	
followed	 by	 Tukey,	 Dunnett	 or	 Newman‐Keuls	 post	 hoc	 test	 was	
employed.	P	 values	of	 less	 than	0.05	were	considered	 statistically	
significant.
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3  | RESULTS
3.1 | Podocin loss leads to nephrotic syndrome
Inactivation	of	podocin	 resulted	 in	 transiently	 reduced	urinary	so‐
dium/creatinine	ratio,	which	was	significantly	reduced	between	day	





creatinine	 ratio	 continued	 to	 increase	until	 the	 end	of	 the	 experi‐
ment	at	28	days.	Oedema	was	regularly	encountered	in	all	Nphs2∆pod 
at	 3	weeks	 of	 the	 experiment.	 These	 results	 show	 in	 detail	 renal	
volume	handling	and	proteinuria	during	 the	development	of	NS	 in	
Nphs2∆pod	and	confirm	previous	published	data.3,18
3.2 | Analysis of renal function, morphology and 
expression of ENaC and its cleavage products in 
nephrotic syndrome during sodium retention
To	 analyse	 renal	 alterations	 in	 more	 detail,	 additional	 animal	 ex‐
periments	at	two	time‐points	after	tamoxifen	administration	were	
chosen:	 day	 5,	 during	 decreased	 sodium/creatinine	 ratio	 and	 day	
9,	when	blood	pressure	starts	to	rise.	Successful	podocin	deletion	
upon	tamoxifen	treatment	was	verified	and	confirmed	(Figure	2A).
Renal	 function	 analysis	 of	 mice	 at	 day	 5	 demonstrated	 reduced	
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and	 tubulointerstitium	 of	 Nphs2∆pod	 were	 assessed	 by	 perform‐
ing	 a	 semi‐quantitative	 analysis	 of	 PAS‐stained	 paraffin	 sections	
(Figure	2B)	using	a	scoring	system	of	0‐4,	where	0	=	no	damage	and	
4	=	maximum	 score	of	 damage	encountered	 in	100%	of	 the	 area	
analysed.	At	day	5,	almost	all	glomeruli	appear	normal	and	a	very	
small	 fraction	 showed	 marginal	 glomerular	 alterations.	 At	 day	 9,	
mild	alteration	at	some	glomeruli	was	encountered	fitting	well	with	
the	significant	increase	in	albuminuria.	In	the	tubulointerstitium,	no	
tubular	alterations	were	 found	except	 for	one	 tubular	cast	at	day	
9.	These	results	demonstrate	that	glomeruli	and	tubulointerstitium	
are	 still	 intact	 at	 those	 time‐points,	which	 is	 congruent	with	nor‐
mal	plasma	creatinine	and	urea	values.	Because	ENaC	was	shown	
to	 play	 a	major	 role	 for	 sodium	 retention	 in	 other	 animal	models	
with	nephrotic	or	nephritic	syndrome,	cortical	and	medullary	ENaC	
expression	pattern	was	determined.	Comparing	Nphs2∆pod	to	con‐














rescence	 intensity	 levels	 of	 cortical	 collecting	ducts	 identified	by	
aquaporin‐2	 expression	 (Figure	3C).	 Semi‐quantified	αNKA	abun‐
dance	from	micrographs	similar	to	(Figure	3C)	after	correction	for	





3.3 | Assessment of Nphs2∆pod at day 17
Additionally,	we	performed	an	animal	experiment	using	control	and	
Nphs2∆pod	which	we	have	stopped	at	17	days	after	tamoxifen	ad‐
ministration	 for	 renal	 analysis	 at	 a	 later	 time‐point	when	NS	was	
fully	developed.	Plasma	analysis	of	Nphs2∆pod	compared	to	control	
revealed	reduced	albumin	and	protein	concentrations	and	increased	
creatinine	 levels	 (Table	 S2).	 Twenty‐four	 hours	 urine	 analysis	 of	
Nphs2∆pod	 compared	 to	 control	 revealed	 increased	 albumin	 and	
protein	excretion,	reduced	creatinine	clearance	and	increased	blood	
pressure.	Ascites	was	regularly	encountered	 in	Nphs2∆pod in com‐
parison	 to	 its	 control.	 Morphologically,	 glomeruli	 demonstrated	
pronounced	 podocyte	 hypertrophy,	 mesangial	 matrix	 deposition	
and	tubular	proteinous	casts	 (Figure	S2A).	Glomerular	 injury	scor‐
ing	showed	that	the	majority	of	glomeruli	 is	still	normal;	however,	
the	 amount	 of	 glomeruli	 appearing	 with	 severe	 alterations	 in‐
creased	 significantly	 (Figure	 S2B).	 Then,	 we	 performed	 Western	
blot	analysis	of	membrane	fractions	from	renal	cortex	and	medulla	
of	Nphs2∆pod	compared	 to	 control	 showing	 significantly	 increased	
ENaC	subunit	and	cleaved	α and γENaC	expression.	This	is	in	agree‐
ment	with	various	previously	published	results	on	volume	handling	
in	 NS.	 Additionally,	 we	 performed	 double	 labelling	 of	 NKA	 with	
aquaporin‐2	 to	 determine	 NKA	 fluorescence	 intensity	 levels	 in	
cortical	collecting	ducts,	which	were	significantly	increased	at	this	
time‐point	(Figure	2D	and	2).
TA B L E  1  Renal	functional	data	of	control	and	Nphs2∆pod	during	
sodium	retention	at	5	and	9	days	after	podocin	inactivation
Day 5 Day 9 n
WT	urine	Na+/crea 36.9	±	1.3 29.7	±	2.3 5‐6
KO	urine	Na+/crea 27.7	±	4.6*  32.0	±	2.1 6‐7
WT	urine	Na+/K+ 0.81	±	0.07 0.68	±	0.09 5‐6







WT	urine	protein	(g/L) 1.36	±	0.06 0.42	±	0.8 5‐6









**P < 0.01. 
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3.4 | Effects of amiloride in the nephrotic syndrome 
development
To	see	and	prove	whether	ENaC	is	activated	and	responsible	for	the	
reduced	 urinary	 sodium/creatinine	 ratio	 early	 in	 the	 NS	 develop‐
ment,	an	additional	animal	experiment	was	conducted	with	amiloride	
(Figure	4).	As	shown	before,	compared	to	their	controls	Nphs2∆pod/
vehicle	 demonstrated	 significantly	 reduced	 urinary	 sodium/creati‐
nine	ratio	between	day	4	and	day	7.	Administration	of	amiloride	to	





induction,	 we	 analysed	 the	 urine	 of	 Nphs2∆pod	 and	 their	 controls	
from	 day	 2	 until	 day	 16.	 In	 controls,	 a	 zymogram‐positive	 band	
was	observed	at	above	260	kDa,	which	also	occurred	 in	 the	urine	
of	Nphs2∆pod	with	 a	 constant	 intensity	 over	 the	 time	 (Figure	 5A).	
Surprisingly,	 already	 at	 day	2	 proteolytic	 activity	was	 observed	 in	











and	 neighbouring	 fractions	with	 the	 same	molecular	weight	were	
pooled.	Fractions	8‐9,	10‐11,	12‐13,	14‐15,	16	and	17‐18	were	tested	




tography	 (LC)‐tandem	mass	 spectrometry	 (MS/MS)	 and	 identified	
proteases	are	summarized	in	Table	3.	The	identified	proteases	were	
typically	 present	 in	multiple	HPLC	 fractions;	 hence	 they	 are	 sum‐
marized	as	a	joint	list.
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to	activate	ENaC	currents	by	proteolytical	processing	of	αENaC.19 
We	have	been	suggested	that	there	maybe	also	other	lysosomal	en‐
zymes,	as	 found	and	highlighted	 in	Table	3,	may	be	able	 to	cleave	
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Cathepsin	D	cleaved	αENaC	at	an	unknown	site	with	resulting	prod‐
ucts	 at	 approx.	 38	 and	 50	 kDa.	 Cathepsin	 E	 and	 legumain	 were	
unable	 to	 process	 αENaC.	 Incubating	 γENaC‐GST	 fusion	 protein	
with	 lysosomal	 enzymes	 showed	 that	 cathepsin	D	 faintly	 cleaved	
γENaC	at	 the	appropriate	 site	with	a	 resulting	product	 at	70	kDa,	
see	positive	control	using	trypsin.	Legumain	processed	γENaC	at	ap‐
prox.	72	kDa.	Cathepsins	B	and	E	were	unable	 to	process	γENaC.	
Incubating	 βENaC‐GST	 fusion	 proteins	 with	 lysosomal	 enzymes	
did	not	result	in	proteolytical	processing,	demonstrating	the	speci‐
ficity	of	lysosomal	enzymes	for	a	specific	subunit.	Next,	we	tested	
the	 ability	 of	 the	 lysosomal	 enzymes	 to	 augment	 ENaC	 activity.	
Incubating	mpkCCDcl14	 cell	 monolayers	with	 cathepsin	 B	 resulted	
in	a	significant	augmentation	of	equivalent	transepithelial	currents	
within	30	minutes	(Figure	5C).	Cathepsin	D	and	legumain	increased	
equivalent	 transepithelial	 currents	 after	 2	 hours.	 For	 comparison,	
trypsin	 increased	equivalent	 transepithelial	current	within	15	min‐
utes.	Cathepsin	E	did	not	alter	the	equivalent	transepithelial	current.
3.7 | Increased cathepsin B expression level in 
Nphs2∆pod
Next,	 the	 proteases	 furin,	 cathepsin	 B	 and	D	were	 analysed	 on	
their	 expression	 level.	Western	 blot	 analysis	 of	 cathepsin	 B	 re‐
vealed	significantly	augmented	expression	in	Nphs2∆pod	compared	
to	their	controls	at	5	and	at	9	days	after	tamoxifen	administration	
(Figure	 6A	 and	 6	 respectively).	 Furin	 and	 cathepsin	D	 remained	
unaltered	 (results	 for	 cathepsin	 D	 are	 not	 shown).	 For	 cellular	













ence	 in	 albumin	 fluorescence	was	 observed	 between	Nphs2∆pod 
and	 control.	 At	 9	 days	 and	more	 pronounced	 at	 17	 days,	 endo‐
cytosed	albumin	 increased	significantly.	As	sodium	retention	oc‐
curs	 between	 days	 4‐7	 it	 seems	 unlikely,	 that	 increased	 urinary	
cathepsin	B	stems	from	the	proximal	tubular	 lysosome	spill	over.	
Additionally,	we	performed	coomassie	staining	of	SDS‐PAGE	and	
Western	 blots	 from	 daily	 spot	 urine	 loaded	 after	 creatinine	 ad‐
justment	 (Figure	S3B).	Albuminuria	was	 starting	at	days	4‐6	and	
unselective	 gross	 proteinuria	 on	 days	 13‐14.	 Western	 blots	 of	
cathepsin	 B	 showed	 increased	 active	 sc‐cathepsin	 B	 expression	
early	 between	 day	 4	 and	 7,	 whereas	 plasminogen	 and	 plasmin	
started	 to	 increase	at	days	13‐14.	We	also	 tested	whether	albu‐
min	may	activate	cathepsin	B	expression	in	cortical	collecting	duct	
cells	and	 incubated	mpkCCDcl14	 cells	with	albumin	at	concentra‐
tions	 ranging	 from	0	 to	20	mg/mL	 for	6	hours	and	at	10	mg/mL	
for	0,	3,	6	and	24	hours;	however,	no	significant	changes	were	ob‐
served	(data	are	not	shown).
3.8 | Impacts of cathepsin B inhibitor CA‐074Me in 
Nphs2∆pod
To	 analyse	whether	 cathepsin	 B	may	 impact	 the	 disease	 progres‐
sion	in	Nphs2∆pod,	an	additional	animal	experiment	was	performed	
with	 control	 and	 Nphs2∆pod	 receiving	 either	 CA‐074Me	 (a	 mem‐
brane‐permeable	cathepsin	B	inhibitor)	or	vehicle	for	14	days	start‐
ing	 on	 the	 day	 after	 the	 first	 tamoxifen	 injection.	 As	 expected	 at	
day	 9,	 Nphs2∆pod	 receiving	 vehicle	 developed	 significantly	 higher	
blood	pressure,	which	remained	high	until	the	end	of	the	experiment	

















Cathepsin B Ctsb P10605
Kallikrein‐1 Klk1 P15947
Glutamyl	aminopeptidase Enpep P16406
Lysosomal protective protein Ctsa P16675

















     |  6551LARIONOV et AL.













point	 of	 sodium	 retention	between	day	4	 and	7	 and	 start	 of	 in‐
creased	 blood	 pressure	 at	 day	 9	 after	 tamoxifen	 administration,	
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analysis	 of	 ENaC	 expression	 pattern	 was	 surprising.	 Increased	
occurrence	 of	 cleaved	αENaC	 fragments	 and	 abundance	 of	 full‐
length	ENaC	subunits	without	changes	 in	aldosterone	and	vaso‐
pressin	levels	were	observed.	An	increased	ENaC	abundance	was	
found	 previously	 in	 many	 other	 proteinuric	 animal	 models.6‐9 
Augmented	 ENaC	 function,	 however,	 seems	 to	 be	 unrelated	 to	
hormonal	 stimulation,	 as	 various	 hormonal	 blockades	 did	 not	




5	and	9	days	 is	of	 functional	 relevance	because	NKA	expression	
levels	from	the	cortical	collecting	duct	are	consistently	increased	
compared	 to	 control	 and	 other	 nephron	 segments	 in	 the	 same	






in	 control/amiloride	 and	 augmented	 strongly	 in	 Nphs2∆pod/ami‐








minemia	and	 fluid	shifts	 from	 intravascular	 to	 the	 interstitial	com‐
partment	can	be	found.
The	 appearance	 of	αENaC	 fragments	 at	 5	 days	 suggests	 the	
existence	of	 local	 proteases;	 therefore,	 the	urine	was	 tested	 for	
proteolytic	 activity.	 Already	 at	 the	 second	 day	 of	 animal	 exper‐
iment,	 elevated	 levels	of	 proteases	 can	be	 found	 in	 the	urine	of	
Nphs2∆pod	which	constantly	 increase	with	the	time.	From	HPLC‐
purified	urine	of	Nphs2∆pod,	we	identified	known	γENaC	cleaving	
proteases,	 such	 as	 prostasin20,21	 kallikrein‐112,22,23	 plasminogen	




by	 cathepsin	B	 resulting	 in	 increased	 relative	 currents	 in	mpkC‐
















the	 glomerular	 filter	 however	 is	 altered	 and	 shows	 albuminuria/










not	account	 for	 increased	cathepsin	B	activity	at	 least	 at	5	days.	
Furthermore,	we	tested	whether	albumin	may	augment	cathepsin	B	
expression	levels;	however,	no	obvious	alterations	were	observed.	
Immunohistochemical	 localization	of	 cathepsin	B	 revealed	 strong	
expression	in	proximal	tubular	profiles	and	to	lesser	extent	in	the	
glomerulus,	distal	tubule	and	collecting	duct	system.	Because	of	the	








fore	ENaC	channel	 activation.	The	 important	 role	of	 cathepsin	B	





the	 chronology	 of	 the	 development	 of	 hallmarks	 of	 the	NS.	 Early	
after	genetic	Nphs2	 deletion,	 sodium	 retention	occurred,	 followed	
by	hypertension	and	gross	proteinuria.	This	early	sodium	retention	is	
based	on	augmented	ENaC	activity	through	proteolytical	processing	
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